BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32043696)

  • 1. Refining the "double two-thirds" rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogs.
    Davies O; Taylor AJ
    Vet Comp Oncol; 2020 Dec; 18(4):548-558. PubMed ID: 32043696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective observational study of dogs with splenic mass rupture suggests potentially lower risk of malignancy and more favourable perioperative outcomes.
    Stewart SD; Ehrhart EJ; Davies R; Khanna C
    Vet Comp Oncol; 2020 Dec; 18(4):811-817. PubMed ID: 32458544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic mass diagnosis in dogs undergoing splenectomy according to breed size.
    O'Byrne K; Hosgood G
    Vet Rec; 2019 May; 184(20):620. PubMed ID: 31040215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of pathological diagnoses made from 87 canine splenic biopsies.
    Day MJ; Lucke VM; Pearson H
    J Small Anim Pract; 1995 Oct; 36(10):426-33. PubMed ID: 8583757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and haematological features of haemangiosarcoma in dogs.
    Ng CY; Mills JN
    Aust Vet J; 1985 Jan; 62(1):1-4. PubMed ID: 4039924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic characteristics of biopsies from dogs undergoing surgery with concurrent gross splenic and hepatic masses: 125 cases (2012-2016).
    Leyva FJ; Loughin CA; Dewey CW; Marino DJ; Akerman M; Lesser ML
    BMC Res Notes; 2018 Feb; 11(1):122. PubMed ID: 29433531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of 43 small breed dogs treated for splenic hemangiosarcoma.
    Story AL; Wavreille V; Abrams B; Egan A; Cray M; Selmic LE
    Vet Surg; 2020 Aug; 49(6):1154-1163. PubMed ID: 32562436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.
    Grimes JA; Prasad N; Levy S; Cattley R; Lindley S; Boothe HW; Henderson RA; Smith BF
    BMC Vet Res; 2016 Dec; 12(1):272. PubMed ID: 27912752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of malignancy and outcomes for dogs undergoing splenectomy for incidentally detected nonruptured splenic nodules or masses: 105 cases (2009-2013).
    Cleveland MJ; Casale S
    J Am Vet Med Assoc; 2016 Jun; 248(11):1267-73. PubMed ID: 27172343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenic masses in dogs. Part 1: Epidemiologic, clinical characteristics as well as histopathologic diagnosis in 249 cases (2000-2011).
    Eberle N; von Babo V; Nolte I; Baumgärtner W; Betz D
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):250-60. PubMed ID: 22911256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breed prevalence and sites of haemangioma and haemangiosarcoma in dogs.
    Srebernik N; Appleby EC
    Vet Rec; 1991 Nov; 129(18):408-9. PubMed ID: 1767484
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of hemangiosarcoma in anemic dogs with a splenic mass and hemoperitoneum requiring a transfusion: 71 cases (2003-2005).
    Hammond TN; Pesillo-Crosby SA
    J Am Vet Med Assoc; 2008 Feb; 232(4):553-8. PubMed ID: 18279091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Nodular Splenic Lesions in 370 Small-Breed Dogs (<15 kg).
    Fernandez S; Lang JM; Maritato KC
    J Am Anim Hosp Assoc; 2019; 55(4):201-209. PubMed ID: 31099604
    [No Abstract]   [Full Text] [Related]  

  • 14. A retrospective study of canine hemangiosarcoma and its association with acanthocytosis.
    Hirsch VM; Jacobsen J; Mills JH
    Can Vet J; 1981 May; 22(5):152-5. PubMed ID: 7195770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass-to-splenic volume ratio and splenic weight as a percentage of body weight in dogs with malignant and benign splenic masses: 65 cases (2007-2008).
    Mallinckrodt MJ; Gottfried SD
    J Am Vet Med Assoc; 2011 Nov; 239(10):1325-7. PubMed ID: 22044329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenomegaly in dogs. Predictors of neoplasia and survival after splenectomy.
    Johnson KA; Powers BE; Withrow SJ; Sheetz MJ; Curtis CR; Wrigley RH
    J Vet Intern Med; 1989; 3(3):160-6. PubMed ID: 2778749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of canine splenic hemangiosarcomas and hematomas with nodular lymphoid hyperplasia or siderotic nodules.
    Cole PA
    J Vet Diagn Invest; 2012 Jul; 24(4):759-62. PubMed ID: 22621950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Efficiency of Splenic Hemangiosarcoma Diagnosis Using Monte Carlo Simulations.
    Herman EJ; Stern AW; Fox RJ; Dark MJ
    Vet Pathol; 2019 Nov; 56(6):856-859. PubMed ID: 31422751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?
    Bray JP; Orbell G; Cave N; Munday JS
    J Small Anim Pract; 2018 Feb; 59(2):85-91. PubMed ID: 29210452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum vascular endothelial growth factor in dogs with haemangiosarcoma and haematoma.
    Frenz M; Kaup FJ; Neumann S
    Res Vet Sci; 2014 Oct; 97(2):257-62. PubMed ID: 25241388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.